SEC-sourced researchBeta
YBGJ
Yubo International Biotech Ltd
Company comparison ↗
Data passport
- CIK
- 0000895464
- Exchange
- OTC
- Business activity
- — · SIC 3845
- Financial inputs
- 6/6
- Filing date
- Mar 31, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 3,470.0000 | Mar 31, 2026 |
| December 2025 | 12,353.0000 | Mar 31, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 12,353.0000 | -1,079,248.0000 | -842,802.0000 | 847,094.0000 | 2,791,297.0000 | Mar 31, 2026 |
| December 2024 | 3,470.0000 | -1,775,648.0000 | -1,337,729.0000 | 1,534,831.0000 | 4,832,522.0000 | Mar 31, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $12.35K | December 2025 | Mar 31, 2026 | 10-K |
| Previous period revenueRevenues | $3.47K | December 2024 | Mar 31, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$1.08M | December 2025 | Mar 31, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$842.8K | December 2025 | Mar 31, 2026 | 10-K |
| Total assetsAssets | $847.09K | December 2025 | Mar 31, 2026 | 10-K |
| Total liabilitiesLiabilities | $2.79M | December 2025 | Mar 31, 2026 | 10-K |